CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024		19,782,311
Beginning balance at Dec. 31, 2024	$ 17,747	$ 19	$ 152,211	$ (134,483)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	179		179
Issuance of shares for vested restricted stock grants (in shares)		33,732
Net gain (loss)	(318)			(318)
Ending balance (in shares) at Mar. 31, 2025		19,816,043
Ending balance at Mar. 31, 2025	$ 17,608	$ 19	152,390	(134,801)
Beginning balance (in shares) at Dec. 31, 2025	20,225,323	20,225,323
Beginning balance at Dec. 31, 2025	$ 20,697	$ 20	153,887	(133,210)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	200		200
Issuance of shares for vested restricted stock grants (in shares)		13,737
Net gain (loss)	$ 636			636
Ending balance (in shares) at Mar. 31, 2026	20,239,060	20,239,060
Ending balance at Mar. 31, 2026	$ 21,533	$ 20	$ 154,087	$ (132,574)